1. Home
  2. ESPR vs NGS Comparison

ESPR vs NGS Comparison

Compare ESPR & NGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ESPR
  • NGS
  • Stock Information
  • Founded
  • ESPR 2008
  • NGS 1998
  • Country
  • ESPR United States
  • NGS United States
  • Employees
  • ESPR N/A
  • NGS 266
  • Industry
  • ESPR Biotechnology: Pharmaceutical Preparations
  • NGS Oilfield Services/Equipment
  • Sector
  • ESPR Health Care
  • NGS Energy
  • Exchange
  • ESPR Nasdaq
  • NGS Nasdaq
  • Market Cap
  • ESPR 305.0M
  • NGS 282.3M
  • IPO Year
  • ESPR 2013
  • NGS 2002
  • Fundamental
  • Price
  • ESPR $1.50
  • NGS $22.58
  • Analyst Decision
  • ESPR Buy
  • NGS Strong Buy
  • Analyst Count
  • ESPR 7
  • NGS 2
  • Target Price
  • ESPR $6.36
  • NGS $26.50
  • AVG Volume (30 Days)
  • ESPR 4.0M
  • NGS 65.9K
  • Earning Date
  • ESPR 03-04-2025
  • NGS 03-17-2025
  • Dividend Yield
  • ESPR N/A
  • NGS N/A
  • EPS Growth
  • ESPR N/A
  • NGS 605.21
  • EPS
  • ESPR N/A
  • NGS 1.28
  • Revenue
  • ESPR $332,314,000.00
  • NGS $152,305,000.00
  • Revenue This Year
  • ESPR $5.51
  • NGS $30.81
  • Revenue Next Year
  • ESPR $1.42
  • NGS $13.48
  • P/E Ratio
  • ESPR N/A
  • NGS $17.67
  • Revenue Growth
  • ESPR 185.66
  • NGS 41.72
  • 52 Week Low
  • ESPR $1.47
  • NGS $16.70
  • 52 Week High
  • ESPR $3.94
  • NGS $29.74
  • Technical
  • Relative Strength Index (RSI)
  • ESPR 34.95
  • NGS 39.36
  • Support Level
  • ESPR $1.47
  • NGS $20.22
  • Resistance Level
  • ESPR $1.61
  • NGS $25.85
  • Average True Range (ATR)
  • ESPR 0.13
  • NGS 1.12
  • MACD
  • ESPR -0.01
  • NGS -0.15
  • Stochastic Oscillator
  • ESPR 7.69
  • NGS 41.62

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

About NGS Natural Gas Services Group Inc.

Natural Gas Services Group Inc provides natural gas compression equipment and services to the energy industry. The company manufactures, fabricates, rents, sells, and maintains natural gas compressors and flare systems for oil and natural gas production and plant facilities. Its operating units include Rental, Sales, and Aftermarket services. The company generates the majority of its revenue by renting out low- to medium-horsepower compression equipment to natural gas production companies in unconventional oil and gas regions of the United States.

Share on Social Networks: